Why the study?
Does human superoxide dismutase reduce myocardial injury in rat models of ischemia and reperfusion?
Population
Rat models of myocardial ischemia and reperfusion
Design
Preclinical
Follow-up
48 hours (in vivo model)
Authors
Loading...
Supports antioxidant strategies in experimental ischemia-reperfusion; leaves open translation to human therapy.
Does human superoxide dismutase reduce myocardial injury in rat models of ischemia and reperfusion?
Human superoxide dismutase provides cardioprotection in rat models of myocardial ischemia and reperfusion, suggesting a direct cytoprotective effect independent of blood elements.
Aoki et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: